July 1, 2020
Gilead Sciences’ top person, Daniel O’Day on 5-day treatment course with remdesivir for $2,340 per patient
Remdevisir has become a popular word these days, along with Covid-19, Coronavirus, the city of Wuhan, and for a good reason. The headline in all the news, the pricing of remdevisir, has been flooding the internet, and pretty much the TV.